Effective inhibition of xenografts of hepatocellular carcinoma (hepg2) by rapamycin and bevacizumab in an intrahepatic model

• Main Authors: Ong, L.-C., Song, I.-C., Jin, Y., Kee, I.H.C., Siew, E., Yu, S., Thng, C.-H., Huynh, H., Chow, P.K.H.
• Other Authors: DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
• Format: Article
• Published: 2014
• Subjects: 18F-FDG-PET; Bevacizumab; Hepatocellular carcinoma; Micro-CT; Micro-PET; Orthotopic xenograft model; Rapamycin; Tumor vasculature
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/110050
• Institution: National University of Singapore

10.1007/s11307-009-0213-4